Edition:
United Kingdom

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

3.44USD
15 Dec 2017
Change (% chg)

$-0.14 (-3.91%)
Prev Close
$3.58
Open
$3.60
Day's High
$3.60
Day's Low
$3.38
Volume
68,174
Avg. Vol
17,923
52-wk High
$32.70
52-wk Low
$3.18

Chart for

About

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development... (more)

Overall

Beta: --
Market Cap(Mil.): $301.51
Shares Outstanding(Mil.): 23.59
Dividend: 23.12
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

29 Nov 2017

BRIEF-Forward Pharma announces completion of corporate restructuring plan

* Forward Pharma announces completion of corporate restructuring plan Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Forward Pharma board approves capital reduction

* Forward Pharma board of directors approves capital reduction and returns EUR 917.7 million to shareholders

01 Sep 2017

BRIEF-Forward Pharma obtains shareholder approval of capital reduction

* Forward Pharma obtains shareholder approval of the planned capital reduction at the extraordinary general meeting

02 Aug 2017

BRIEF-Forward Pharma announces planned distribution of EUR 19.45 per share to shareholders

* Forward Pharma announces planned distribution of EUR 19.45 per share to shareholders

18 Jul 2017

Earnings vs. Estimates